* Heartbeam Inc reported a quarterly adjusted loss of 19 cents per share for the quarter ended in June, lower than the same quarter last year, when the company reported EPS of -16 cents. The mean expectation of two analysts for the quarter was for a loss of 16 cents per share. Wall Street expected results to range from -18 cents to -15 cents per share.
* Reported revenue was zero; analysts expected zero.
* Heartbeam Inc's reported EPS for the quarter was a loss of 19 cents.
* The company reported a quarterly loss of $4.96 million.
* Heartbeam Inc shares had fallen by 11.7% this quarter and lost 3.4% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by about 8.3% in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced medical equipment & technology peer group is "hold."
Wall Street's median 12-month price target for Heartbeam Inc is $5.00 This summary was machine generated from LSEG data August 15 at 05:29 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -0.16 -0.19 Missed
Mar. 31 2024 -0.15 -0.17 Missed
Dec. 31 2023 -0.13 -0.15 Missed
Sep. 30 2023 -0.13 -0.13 Met
Comments